Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Falling Comet
182.2200 -0.57 (-0.31%)
NSE Dec 24, 2025 15:31 PM
Volume: 501.6K
 

182.22
-0.31%
Dynamic Levels
Marksans R&D; capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development and conducting stability studies. The company has a team of over 50 experienced scientists specializing in formulation development and analytical development. The conpany has possessed end-to-end capabilities from Lab scale development to Pilot scale up and from commercializing the product for large...
Number of FII/FPI investors decreased from 159 to 146 in Sep 2025 qtr
More from Marksans Pharma Ltd.
Recommended